Angioedema - 189 Studies Found
Completed |
: Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE) : Hereditary Angioedema : 2007-04-04 :
|
Completed |
: Analysis of the Availability of the Treatments for ACE-I and ARB-induced Angioedema : ACE-I and ARB-induced Angioedema. : 2016-07-05 |
Active, not recruiting |
: A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema : Hereditary Angioedema (HAE) : 2011-06-28 : Drug: icatibant Single dose of icatibant 0.4 mg/kg subcutaneous(SC) up to a maximal dose of 30 mg |
Recruiting |
: Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema : Acute ACE-induced Angioedema : 2013-04-26 :
|
Completed |
: Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects : Hereditary Angioedema : 2007-02-07 : Drug: C1 esterase inhibitor [human] (C1INH-nf) |
Completed |
: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks : Hereditary Angioedema : 2007-02-21 : Biological: C1 esterase inhibitor [human] (C1INH-nf) |
Completed |
: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks : Hereditary Angioedema : 2007-04-17 : Biological: C1 esterase inhibitor [human] (C1INH-nf) |
Completed |
: A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema : Hereditary Angioedema Types I and II : 2013-07-29 :
|
Recruiting |
: Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients : Hereditary Angioedema : 2011-05-19 : Drug: rhC1INH Patients up to 84 kg will receive one i.v. injection of Ruconest at a dose of 50 U/kg. The |
Completed |
: Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE) : Hereditary Angioedema : 2007-04-04 : Drug: ecallantide solution for SC injection, one 30 mg dose per HAE attack |